Approval · Notice of Compliance 2000 · 1999
BREXIDOL: Notice of Compliance 2000
Issued March 2, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2000
- Date
- March 2, 1999
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Nsaid analgesic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BREXIDOL | 02239599 | Cancelled Post Market |
Medicinal ingredients
- PIROXICAM-B-CYCLODEXTRIN 191.2 MG per TAB